1-(tert-Butyl)-2-chloro-1H-imidazole

Catalog No. :
ACTRIV145
CAS No. :
1053655-54-1
Molecular Formula :
C7H11ClN2
Molecular Weight :
158.63

IUPAC Name:1-(tert-butyl)-2-chloro-1H-imidazole

1-(tert-Butyl)-2-chloro-1H-imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$219.00Login to see priceIn stockInquiry
250mg95%$284.00Login to see priceIn stockInquiry
1g95%$705.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-Butyl)-2-chloro-1H-imidazole
IUPAC Name1-(tert-butyl)-2-chloro-1H-imidazole
MDL No.MFCD10699140
Molecular FormulaC7H11ClN2
Molecular Weight158.63
SMILESCC(C)(C)N1C=CN=C1Cl
InChI KeyHGALHYIWAIAMJQ-UHFFFAOYSA-N
Synonym1053655-54-1 | 1-Tert-butyl-2-chloro-1H-imidazole | 1-(tert-Butyl)-2-chloro-1H-imidazole | 2-Chloro-1-(tert-butyl)-1H-imidazole | 1-tert-butyl-2-chloroimidazole | SCHEMBL21341550 | DTXSID60653273 | MFCD10699140 | AKOS006303196 | AB92403 | AS-40869 | CS-0315296 | FT-0685444 | J-508
CAS No.1053655-54-1
PubChem CID37818422

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTRIV145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUPWL716 route compound structure diagram
    ACUPWL71616265-04-6 In Stock
  4. Then
  5. ACTRIV145 route product structure diagram
    ACTRIV1451053655-54-1 In Stock
Inquiry

2. ACTRIV145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUPWL716 route compound structure diagram
    ACUPWL71616265-04-6 In Stock
  4. Then
  5. ACTRIV145 route product structure diagram
    ACTRIV1451053655-54-1 In Stock
Inquiry

Comments (0)